Global Immunology Franchise Lead, Vaccines R&D

Sanofi; Washington (District of Columbia); On-site; USD 250,000 - 350,000; Full time

Benefits offered by this job

Mentoring and career development

International mobility programs

Global collaboration with leading PhD/

Cross-continental teams

Job summary

Sanofi seeks an Immunology Franchise Lead for Vaccines R&D Global Clinical Development to shape immunology strategy across the vaccine portfolio and drive breakthroughs in disease prevention on a global scale.

You will interface with Clinical Franchise Leaders, BIOS leaders, and regulatory teams to provide scientific guidance, lead a global team, and influence portfolio prioritization across multiple development stages.

Qualifications

• PhD in Immunology, Virology, Bacteriology, Microbiology, or related field with 10+ years of industry experience or a mix of industry and academia.
• MD in Immunology, Virology, Bacteriology, Microbiology, or related field with 5+ years of industry experience or a mix of industry and academia.
• 3+ years of direct people leadership experience.

Responsibilities

• Lead the immunology strategy across the vaccine franchise, overseeing immunogenicity, virology, and bacteriology endpoints.
• Serve as the primary immunology interface with Clinical Franchise Leadership and One Research segment heads for guidance across development and lifecycle.
• Establish and manage strategic partnerships with external experts, academic institutes, and key opinion leaders.

Skills

Immunology leadership

Vaccine development

Cross-functional leadership

Regulatory submissions

Education

PhD in Immunology

MD in Immunology

Job description

Sanofi seeks an Immunology Franchise Lead for Vaccines R&D Global Clinical Development to shape immunology strategy across the vaccine portfolio and drive breakthroughs in disease prevention on a global scale.

You will interface with Clinical Franchise Leaders, BIOS leaders, and regulatory teams to provide scientific guidance, lead a global team, and influence portfolio prioritization across multiple development stages.